BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15062764)

  • 1. The ADVIA Centaur immunoassay system--designed for infectious disease testing.
    Okrongly D
    J Clin Virol; 2004 Apr; 30 Suppl 1():S19-22. PubMed ID: 15062764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ADVIA Centaur infectious disease assays: a technical review.
    Dwyer R
    J Clin Virol; 2004 Apr; 30 Suppl 1():S1-5. PubMed ID: 15062760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on laboratory productivity with infectious disease assays on the Bayer ADVIA Centaur Immunoassay System.
    Dati F
    Clin Lab; 2004; 50(1-2):53-61. PubMed ID: 15000221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with the IVDD performance evaluations of the ADVIA Centaur infectious disease assays.
    van Helden J; Denoyel GA
    J Clin Virol; 2004 Apr; 30 Suppl 1():S16-8. PubMed ID: 15062763
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P; Pickard G; Gammie A; Atkins M
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.
    Dati F; Denoyel G; van Helden J
    J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.
    Denoyel G; van Helden J; Bauer R; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):75-82. PubMed ID: 15000223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a new HIV 1/O/2 assay on the Bayer ADVIA Centaur immunoassay system.
    van Helden J; Denoyel G; Freeman J; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):83-90. PubMed ID: 15000224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation of the ADVIA Centaur anti-HBe and HBeAg assays.
    van Helden J; Cornely C; Dati F; Levy HR; Bal T; Seeger M; Wright T; Baker L
    J Clin Virol; 2008 Oct; 43(2):169-75. PubMed ID: 18635392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers.
    Chen D; Kaplan L; Liu Q
    Clin Chim Acta; 2005 May; 355(1-2):41-5. PubMed ID: 15820476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays.
    Louisirirotchanakul S; Khupulsup K; Akraekthalin S; Chan KP; Saw S; Aw TC; Cho DH; Shin MG; Lim J
    J Med Virol; 2010 May; 82(5):755-62. PubMed ID: 20336717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.
    Miedouge M; Legrand-Abravanel F; Lalanne C; Saune K; Izopet J
    J Clin Virol; 2009 Feb; 44(2):134-7. PubMed ID: 19110466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance evaluation of a specific IgE assay developed for the ADVIA centaur immunoassay system.
    Petersen AB; Gudmann P; Milvang-Grønager P; Mørkeberg R; Bøgestrand S; Linneberg A; Johansen N
    Clin Biochem; 2004 Oct; 37(10):882-92. PubMed ID: 15369719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors].
    Cavdar E; Kuştimur S; Doğruman Al F
    Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of the Bayer ADVIA Centaur HIV 1/O/2 enhanced (EHIV) assay.
    Schappert J; Wians FH; Schiff E; Smalley D; Gambardella R; Lee WM; Wu J; Keiser P; Peterson D; De Medina M; Baker L; Preisel-Simmons B
    Clin Chim Acta; 2006 Oct; 372(1-2):158-66. PubMed ID: 16769045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determination.
    Haltmayer M; Mueller T; Gegenhuber A; Poelz W
    Clin Lab; 2004; 50(3-4):175-80. PubMed ID: 15074472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
    La'ulu SL; Roberts WL
    Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of the ARCHITECT anti-HCV assay.
    Jonas G; Pelzer C; Beckert C; Hausmann M; Kapprell HP
    J Clin Virol; 2005 Oct; 34(2):97-103. PubMed ID: 16122974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.